Richard D. Truesdell, Jr.
Lawyers
Filters
Kinsale Capital Group, Inc. Follow-On Offering
Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $70 million follow-on offering of 741,750 shares of common stock of Kinsale…
PTC Therapeutics, Inc. $125 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by PTC Therapeutics, Inc. of its shares of common stock for up to an aggregate amount of $125…
ProSight Global, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $110 million initial public offering of 7,857,145 shares of common stock by…
The Medicines Company $172.5 Million Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by The Medicines Company of 5,227,273 shares of common stock for approximately $172.5 million, which…
The Home Depot, Inc. $1.4 Billion Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering of $1 billion aggregate principal amount of 2.950% notes due 2029 and $400 million aggregate principal…
IAC $1.15 Billion Exchangeable Senior Notes Offerings and Related Exchangeable Note Hedge and Warrant Transactions
Davis Polk advised the initial purchasers in connection with Rule 144A offerings by IAC FinanceCo 2, Inc. and IAC FinanceCo 3, Inc., wholly owned subsidiaries of IAC/InterActiveCorp (“IAC”)…
Hostess Brands $106 Million Secondary Offering
Davis Polk advised the sole bookrunner in connection with the $106.48 million SEC-registered secondary offering of 8,000,000 shares of Class A common stock of Hostess Brands, Inc. by…
Applied Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $40 million initial public offering of common stock of Applied Therapeutics, Inc. Applied…
Bristol-Myers Squibb Company $19 Billion Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…